Project Title: Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3)
In October 2011, the United States Agency for International Development (USAID) and the President’s Malaria Initiative (PMI) awarded MCDI the Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3). The ARM3 Consortium is led by MCDI and initially consisted of Management Sciences for Health (MSH), John’s Hopkins University Center for Communications Programs.
In collaboration with USAID/Benin’s PMI, ARM3 seeks to assist the Government of Benin (GOB) in improving malaria health outcomes in accordance with the NMCP’s guidelines and standards. The primary objective of ARM3 is to help the GOB achieve the PMI target of reducing malaria-associated mortality by 70% compared to pre-initiative levels in Benin. In support of this PMI objective, the ARM3 program’s specific goal is to increase coverage and use of key life-saving malaria interventions in support of Benin’s NMCP Strategy. ARM3 seeks to complements and leverage the efforts of USAID through its APC and ANCRE projects as well as other donors (GFATM, UNICEF, WHO) to reach the NMCP’s goals of eliminating malaria as a public health problem in Benin in 2030.
Partners: Management Sciences for Health (MSH), John’s Hopkins University Center for Communications Programs (JHU – CCP)